Moleculin Receives European Medicines Agency Approval to Expand Phase 3 MIRACLE Clinical Trial

Stock Information for Qutoutiao Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Qutoutiao Inc.

Moleculin Participates in the Virtual Investor "What's Your Story" Summer Spotlight On-Demand Conference
JTC Team Virtual Investor "What's Your Story" Summer Spotlight On-Demand Conference Now Live
Moleculin Engages Industry Veteran Adriano Treve to Explore Accelerated Strategic Partnerships
Moleculin Expands Phase 3 MIRACLE Clinical Trial into the Country of Georgia, Enrollment Update and Future Plans
Moleculin Announces $5.9 Million Public Offering
Moleculin Participates in Virtual Investor "What This Means" Segment
Moleculin Receives Positive FDA Feedback on Pediatric Study Plan for Annamycin in Children with R/R AML
Moleculin Participates in Virtual Investor "What This Means" Segment

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.